Engineering Agonistic Bispecifics to Investigate the Influence of Distance on Surface-Mediated Complement Activation
The Journal of Immunology · 2024
DOI: 10.4049/jimmunol.2400091 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Sebastiaan M W R Hamers und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Complement Activation, Antibodies, Bispecific, Protein Engineering. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Research Council, EC | ERC | HORIZON EUROPE European Research Council (ERC), Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO).
Abstract (Originalsprache)
The development of agonists capable of activating the human complement system by binding to the C1 complex presents a novel approach for targeted cell killing. Bispecific nanobodies and Abs can successfully use C1 for this purpose; however, efficacy varies significantly between epitopes, Ab type, and bispecific design. To address this variability, we investigated monomeric agonists of C1 in the form of bispecific nanobodies, which lack Fc domains that lead to oligomerization in Abs. These therefore offer an ideal opportunity to explore the geometric parameters crucial for C1 activation. In this study, we explored the impact of linker length as a metric for Ag and epitope location. DNA nanotechnology and protein engineering allowed us to design linkers with controlled lengths and flexibilities, revealing a critical range of end-to-end distances for optimal complement activation. We discovered that differences in complement activation were not caused by differential C1 activation or subsequent cleavage of C4, but instead impacted C4b deposition and downstream membrane lysis. Considering the importance of Ab class and subclass, this study provides insights into the structural requirements of C1 binding and activation, highlighting linker and hinge engineering as a potential strategy to enhance potency over specific cellular targets. Additionally, using DNA nanotechnology to modify geometric parameters demonstrated the potential for synthetic biology in complement activation. Overall, this research offers valuable insights into the design and optimization of agonists for targeted cell killing through complement activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, the Netherlands.
- Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands.
- School of Chemistry, University of Bristol, Bristol, United Kingdom.
- School of Biochemistry, University of Bristol, Bristol, United Kingdom.
ORCID-Profile: Sebastiaan M W R Hamers, Aimee L Boyle, Thomas H Sharp
Förderung
- European Research Council
- EC | ERC | HORIZON EUROPE European Research Council (ERC)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)
Zitieren
APA
Hamers, S. M. W. R., Boyle, A. L., & Sharp, T. H. (2024). Engineering Agonistic Bispecifics to Investigate the Influence of Distance on Surface-Mediated Complement Activation. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2400091
Vancouver
Hamers SMWR, Boyle AL, Sharp TH. Engineering Agonistic Bispecifics to Investigate the Influence of Distance on Surface-Mediated Complement Activation. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2400091
BibTeX
@article{Hamers2024,
author = {Hamers, Sebastiaan M W R and Boyle, Aimee L and Sharp, Thomas H},
title = {Engineering Agonistic Bispecifics to Investigate the Influence of Distance on Surface-Mediated Complement Activation},
journal = {The Journal of Immunology},
year = {2024},
doi = {10.4049/jimmunol.2400091}
}
EUVIMED